HF
INTS icon

HRT Financial’s Intensity Therapeutics INTS Stock Holding History

HRT Financial’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-996
Closed -$7K – 3244
2025
Q2 		$7K Buy
+996
New +$20.5K ﹤0.01% 2472
2024
Q3 		– Sell
-635
Closed -$77K – 2764
2024
Q2 		$77K Buy
+635
New +$72K ﹤0.01% 1793
2024
Q1 		– Sell
-1,276
Closed -$273K – 2664
2023
Q4 		$273K Buy
+1,276
New +$134K ﹤0.01% 1656

Other funds holding INTS

SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
SFGP
Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.32B AUM 23.07% 1-Year Est. Return

HRT Financial's INTS Position: Q3 2025 in Review

HRT Financial sold out of Intensity Therapeutics (INTS) in Q3 2025, closing a stake of 996 shares — an estimated $7K sold.

HRT Financial first reported a position in INTS in Q4 2023 and held it in 3 quarters. The position peaked at $273K in Q4 2023. 26 funds tracked by Wall St. Rank hold INTS as of Q3 2025.

  • HRT Financial reported no remaining Intensity Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 996 Intensity Therapeutics shares in Q3 2025, an estimated $7K.
  • HRT Financial first reported a position in Intensity Therapeutics in Q4 2023 and held it in 3 quarters.
  • HRT Financial's Intensity Therapeutics position peaked at $273K in Q4 2023.
  • 26 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.